In glioma grade IV, highly activated DEGs included STOM, IGHG4, CXCL13, MMP13, and CAPN6, while highly downregulated DEGs included JAZF1-AS1 and ELDR (Figure 4B). The gene discussed is CXCL13; the disease is central nervous system cancer.